These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3924827)

  • 81. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
    Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
    J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator.
    Gordon DL; Krueger RA; Quie PG; Hostetter MK
    J Immunol; 1985 May; 134(5):3339-45. PubMed ID: 3980996
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus.
    Spika JS; Verbrugh HA; Verhoef J
    Infect Immun; 1981 Nov; 34(2):455-60. PubMed ID: 7309234
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
    Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
    J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The role of different K antigens of Escherichia coli in phagocytosis by polymorphonuclear leukocytes.
    Verweij-Van Vught AM; Namavar F; Peerbooms PG; Sparrius M; Maclaren DM
    J Med Microbiol; 1984 Apr; 17(2):141-50. PubMed ID: 6142958
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Role of antibody and complement in opsonization of group B streptococci.
    Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
    Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunochemistry of Pseudomonas aeruginosa lipopolysaccharides and high-molecular-weight polysaccharides.
    Pier GB
    Rev Infect Dis; 1983; 5 Suppl 5():S950-6. PubMed ID: 6197738
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.
    Mishra M; Ressler A; Schlesinger LS; Wozniak DJ
    Infect Immun; 2015 Aug; 83(8):3006-14. PubMed ID: 25964476
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Effect of Pseudomonas immunoglobulin on the antibacterial activity of human phagocytes].
    Just HM; Termöhlen M; Pinkawa M; Daschner FD
    Infection; 1987; 15 Suppl 2():S42-6. PubMed ID: 3112019
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Serum-induced lysis of Pseudomonas aeruginosa.
    Meshulam T; Verbrugh H; Verhoef J
    Eur J Clin Microbiol; 1982 Feb; 1(1):1-6. PubMed ID: 6816583
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clindamycin enhances opsonization of Staphylococcus aureus.
    Milatovic D; Braveny I; Verhoef J
    Antimicrob Agents Chemother; 1983 Sep; 24(3):413-7. PubMed ID: 6638997
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Complement pathway activity in the opsonization of mutant strains of Salmonella typhimurium.
    Shaio MF; Rowland H
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 May; 19(2):137-52. PubMed ID: 3102176
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
    Marshall BC; Carroll KC
    Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.
    Kuo CF; Lin YS; Chuang WJ; Wu JJ; Tsao N
    Infect Immun; 2008 Mar; 76(3):1163-9. PubMed ID: 18174338
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Opsonic activity of antisera to ribosomal vaccine fractions with live and formalinized Pseudomonas aeruginosa.
    Lieberman MM; Allen RC
    Can J Microbiol; 1986 Jun; 32(6):531-3. PubMed ID: 3089571
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum.
    Mahenthiralingam E; Speert DP
    Infect Immun; 1995 Nov; 63(11):4519-23. PubMed ID: 7591095
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli.
    Goldberg JB; Hatano K; Meluleni GS; Pier GB
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10716-20. PubMed ID: 1279692
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
    Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.
    Pier GB; Koles NL; Meluleni G; Hatano K; Pollack M
    Infect Immun; 1994 Apr; 62(4):1137-43. PubMed ID: 8132318
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms.
    Jensen ET; Kharazmi A; Lam K; Costerton JW; Høiby N
    Infect Immun; 1990 Jul; 58(7):2383-5. PubMed ID: 2114367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.